SANUWAVE Q3 revenue $4.2M (+12% YoY); gross margin 85%; turns EBITDA positive in October

SANUWAVE Health, Inc.

2022-Q3 EPS reported $0.00 revenue$11,242,000

Q3 revenue $4.2M, +12% YoY; nine-month revenue $11.2M, +28.5% YoY.
Gross margin improved to 85% from 58% YoY; nine-month margin 77% vs 58%.
Operating loss narrowed to $1.8M from $3.4M YoY; nine-month operating expense down 17.6%.
Company became EBITDA positive in October 2022 and expects Q4 profitability.
Post-quarter raised ~$2M for sales hiring and inventory; terms consistent with August financing.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

SANUWAVE Health, Inc. reported the quarter, starting April 1, 2022 and ending June 30, 2022 results: revenue $3.9 million.

Period: the quarter, starting April 1, 2022 and ending June 30, 2022
Revenue: $3.9 million
Result: reported results

Exact text from the filing

Revenues for the quarter, starting April 1, 2022 and ending June 30, 2022, came in at $3.9 million.

View on SEC.gov

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

SANUWAVE Health, Inc. reported the 3 months ended September 30, 2022 results: revenue $4.2 million.

Period: the 3 months ended September 30, 2022
Revenue: $4.2 million
Result: reported results

Exact text from the filing

Revenues increased 12% to $4.2 million for the 3 months ended September 30, 2022, versus $3.7 million for the same period last year.

View on SEC.gov

44 earnings releases filed in the last 30 days. Browse all earnings releases →

SANUWAVE Health, Inc. filing history →

Source: SEC EDGAR

accession 0001140361-22-041531

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.